[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"drug-induced-inflammatory-myositis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:drug-induced-inflammatory-myositis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100474179","follow-up-of-patients-with-inflammatory-myopathies-associated-with-a-biobank-100474179",false,"NCT05454527","Follow-up of Patients With Inflammatory Myopathies Associated With a Biobank","Follow-up of a Cohort of Patients With Inflammatory Myopathies Associated With a Biobank: MASC 2 Project (Myositis, Muscles, DNA\u002FRNA Serum Cells)","MASC2","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Suspicion of Myositis defined according to reference classifications: Dermatomyositis (DM), polymyositis (PM) defined as early as 1975 by Bohan and Peter, inclusion myositis (IM) according to the criteria of Griggs et al, 1995 and autoimmune necrotizing myopathy (ANM) by Hoogendijk et al, in 2004 and iatrogenic (e.g. drug-induced) myositis.\n* No opposition from patients to the use of their data\n* Signature of consents for the constitution of the biobank and the genetic analyses\n\nExclusion Criteria:\n\n* Patients under AME\n* Patients under legal protection","ALL","18 Years",{"count":20,"type":21},4000,"ESTIMATED","OBSERVATIONAL","Myositis are rare diseases for which the development of a cohort associated with a bank of biological samples (biobank) will allow for the conduct of researches to better delineate the underlying pathophysiology and find cures. This prospective cohort of patients with myositis will allow for identification of factors favouring the occurrence of myositis, whether they are constitutional (genetic) or acquired (environmental or drug). Different subgroups of myositis used for prognostication will be identified based on clinico-demographical variables, the nature of the organs involved beyond peripheral muscles (cardiac, diaphragm) and biomarkers abnormalities",[25,26,27],"Inflammatory Myositis","Idiopathic Inflammatory Myositis","Drug-induced Inflammatory Myositis","RECRUITING","2025-04-22",{"date":31,"type":32},"2025-04-23","ACTUAL",{"date":34,"type":32},"2022-10-26",{"date":36,"type":21},"2057-10-26",{"name":38,"class":39},"Assistance Publique - Hôpitaux de Paris","OTHER",2]